Paper Review Records
全部论文审稿周期
11 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
155
天
A novel DMTN :: HMGA2 rearrangement drives aberrant reactivation of HMGA2 with profibrotic and type I interferon–suppressive signaling
作者
Yan Lin; Sujuan Zhou; Mei Yang; Nan Chen; Jintao Xu; Xingping Lang; Fan Yang; Sheng Xiao; Lijun Meng; Shouli Wang; Liying Zhang展开收起
作者单位
1. Department of Hematology, The First People's Hospital of Changzhou; 2. Third Affiliated Hospital of Soochow University; 3. Advanced Molecular Pathology Institute of Soochow University and SANO; 4. Suzhou Sano Precision Medicine Ltd, SANO Medical Laboratories; 5. Department of Pathology; 6. School of Basic Medical Sciences of Soochow University; 7. Department of Hematology; 8. Affiliated Hospital of Nantong University; 9. The Second Affiliated Hospital of Soochow University展开收起
99
天
RecurIndex-derived molecular features associated with total pathological complete response in triple-negative breast cancer: An exploratory prospective cohort study with single-cell transcriptomic contextualization
作者
Meilin Chen; Xiwen Yan; Qifan Chen; Jiayi Bei; Zheng Pan; Tian Zhang; Weihao Cheng; Lu Xu; Feng Jin; Yan Gao; Zining Jin; Ang Zheng展开收起
作者单位
1. Beijing Chaoyang Hospital, Capital Medical University, Beijing Chaoyang Hospital; 2. Department of Breast Surgery, The First Hospital of China Medical University; 3. Department of Medical Oncology, The First Hospital of China Medical University; 4. Department of Human Anatomy, School of Basic Medical Sciences, Capital Medical University展开收起
92
天
UBE2S promotes gastric cancer progression through RACGAP1 stabilization associated with K292-dependent K63-linked ubiquitination
作者
HeFei Cheng; Ziqing Zhou; Qirun Cheng; Ziqi Sui展开收起
作者单位
1. Department of Gastroenterology, The First People’s Hospital of Linping District; 2. Department of Gastroenterology, The Second Affiliated Hospital of Zhejiang Chinese Medical University; 3. Department of Gastroenterology, Zhejiang Hospital展开收起
111
天
ARHGAP40 suppresses clear cell renal cell carcinoma progression and is associated with altered glutamine-related metabolism and redox balance
作者
Na You; Xiaoxia Wang; Caizhu Wang; Long Ma; Yanli Lyu; Han Liu; Fan Yang; Jiandong Wang; Longjiang Zhang; Jufang Wang展开收起
作者单位
1. School of Biology and Biological Engineering, South China University of Technology; 2. Guangzhou Huayin Medical Laboratory Center Co, Ltd; 3. Guangzhou Huayin Health Group Co., Ltd; 4. Department of Pathology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University; 5. Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University; 6. School of Life Sciences, Jiangsu Key Laboratory for Molecular and Medical Biotechnology, Nanjing Normal University展开收起
178
天
Inhibition of WNT signaling sensitizes CRC cells to anti-tumor effects of retinoids: basis for new drug combinations in oncology
作者
Victoria O. Hunsu; Caroline O. B. Facey; Lynn M. Opdenaker; Bruce M. Boman展开收起
作者单位
1. Cawley Center for Translational Cancer Research, Helen F. Graham Cancer Center & Research Institute; 2. Department of Biological Sciences, University of Delaware; 3. Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University展开收起
108
天
Elevated miR-103b in exosomes derived from brain-metastatic triple-negative breast cancer cells remodels the brain pre-metastatic niche (PMN)
作者
Li Zhou; Jin Ke; Shanlan Zhang; Sufang Xiao; Hui Zhang; Shan Liu; Li Liu; Mingan Liu; Zuohua Lu; Songguo Zheng展开收起
作者单位
1. Department of Oncology, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; 2. Department of Clinical Laboratory, Pudong Gongli Hospital, Shanghai University of Medicine & Health Sciences; 3. Department of Immunology, The School of Cell & Gene Therapy, Songjiang Research Institute and Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; 4. State Key Lab of Innovative Immune Therapy, Shanghai Jiao Tong University展开收起
FAQ
CANCER BIOLOGY & THERAPY审稿要多久?
截至2026-11-19,CrushSCI 收录了 CANCER BIOLOGY & THERAPY 的 11 篇完整审稿记录。最快一篇从收稿到录用用了 53 天(DNA polymerase theta (Polθ): a novel candidate for targeted cancer therapy,2026-05-18 收稿,2026-07-10 录用),最慢一篇用了 272 天;平均 116.2 天,中位数 99 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
